Last reviewed · How we verify

NCT06772688: OGS

Custom Made Plate in Orthognathic Surgery

Completed NA Last updated 17 January 2025
What this trial tests

NA trial testing orthognathic surgery in Maxillary Prognathism in 8 participants. Completed in 3 December 2024.

Timeline
3 April 2023
Primary endpoint
12 October 2024
3 December 2024

Quick facts

Lead sponsorFaculty of Dental Medicine for Girls
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment8
Start date3 April 2023
Primary completion12 October 2024
Estimated completion3 December 2024
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Faculty of Dental Medicine for Girls — full company profile →

Who can join

Adults 18 to 40, any sex, with Maxillary Prognathism or Maxillary Retrusion. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Orthognathic surgery has traditionally been used to correct dentofacial deformities. Conventional methods rely on 2D radiographic images, occlusal splints, and dental casts, but these approaches have limitations, such as errors during face-bow transfer. Technological advancements, including 3D imaging, virtual surgical planning (VSP), and computer-aided design and manufacturing (CAD/CAM), have improved the precision and outcomes of orthognathic surgery.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of orthognathic surgery

Trials testing the same drug.

Other Faculty of Dental Medicine for Girls trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06772688.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing